Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Paraneoplastic Syndromes × gamma-Globulins × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Leukemia 4 Neoplasms, Plasma Cell 3 Neoplasms 3 Lymphoma 3 Infections 3 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Paraneoplastic Syndromes 1 Myeloproliferative Disorders 1 Myelodysplastic-Myeloproliferative Diseases 1 Myelodysplastic Syndromes 1 Myasthenia Gravis 1 Leukemia, Myeloid, Chronic-Phase 1 Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 1 Leukemia, Myeloid, Acute 1 Leukemia, Myeloid, Accelerated Phase 1 Leukemia, Lymphocytic, Chronic, B-Cell 1 Congenital Abnormalities 1 Anemia, Refractory, with Excess of Blasts 1 Anemia, Refractory 1

Interventions

gamma-Globulins 1 Tacrolimus 1 Salpingo-oophorectomy 1 Magnetic Resonance Imaging 1 Immunologic Tests 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06373211 2025-02-17

NESPA

Assistance Publique - Hôpitaux de Paris

Phase 2 Recruiting

Paraneoplastic Syndromes

Data powered by HemOnc (CC BY 4.0) Colophon ⚡